Five Star Equities Issues New Research Reports on ICLD, OHRP, ROVI and SPNC


Follow this company

Companies Mentioned

NASDAQ:ICLD / NASDAQ:OHRP / NASDAQ:ROVI / NASDAQ:SPNC
04/09/2014 [ACCESSWIRE]

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

InterCloud Systems Inc. (NASDAQ: ICLD) shares dropped 21.32 percent to close at $6.09 a share Tuesday. The stock traded between $5.52 and $6.86 on volume of 1.71 million shares traded. The company reported a net loss of $23.4 million for the fourth quarter of 2013, compared to a net loss of $0.4 million a year ago. Shares of InterCloud Systems are down approximately 66.0 percent year-to-date.

Get more information on InterCloud Systems and free access to the in-depth equity report at:  
www.FiveStarEquities.com/ICLD

OHR Pharmaceutical Inc. (NASDAQ: OHRP) shares fell 18.20 percent to close at $9.84 a share Tuesday. The stock traded between $9.70 and $10.57 on volume of 1.92 million shares traded. The company announced a registered direct offering of 1.8 million shares of common stock at a price of $10.00 per share. Shares of OHR Pharmaceutical are up approximately 25.0 percent year-to-date.

Get more information on OHR Pharmaceutical and free access to the in-depth equity report at:  
www.FiveStarEquities.com/OHRP

Rovi Corporation (NASDAQ: ROVI) shares dropped 11.87 percent to close at $20.50 a share Tuesday. The stock traded between $19.50 and $23.42 on volume 6.58 million shares traded. A federal appeals court has ruled that Amazon.com did not infringe on any of Rovi’s patents related to electronic programming guides. Shares of Rovi are up approximately 4.0 percent year-to-date.

Get more information on Rovi free access to the in-depth equity report at:  
www.FiveStarEquities.com/ROVI

The Spectranetics Corporation (NASDAQ: SPNC) shares declined 11.87 percent to close at $23.01 a share Tuesday. The stock traded between $22.00 and $24.20 on volume 2.95 million shares traded. Analysts at Canaccord Genuity have recently lowered the company’s price target to $30.00 from $35.00. Shares of Spectranetics are down approximately 8.0 percent year-to-date.

Get more information on Spectranetics and free access to the in-depth equity report at:  
www.FiveStarEquities.com/SPNC

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:       
Five Star Equities
info@fivestarequities.com

COMMENTS

Leave a comment...
 * 

Your Name
 *